Teva's Innovative Drug Portfolio Fuels Growth as Company Raises Outlook, Transitions to Direct NYSE Listing
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA ) stock is trading higher on Wednesday after the company reported second-quarter earnings and a direct U.S. listing. • Teva Pharmaceutical Indus shares are powering higher. What’s behind TEVA gains? NYSE Listing Transition Teva announces the replacement of its American De